An Antibody Reactive with Domain 4 of the Platelet-derived Growth Factor β Receptor Allows BB Binding while Inhibiting Proliferation by Impairing Receptor Dimerization
Open Access
- 1 July 1997
- journal article
- Published by Elsevier
- Vol. 272 (28) , 17400-17404
- https://doi.org/10.1074/jbc.272.28.17400
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Dimerization of cell surface receptors in signal transductionCell, 1995
- The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transductionCell, 1995
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Isolation of a novel cytotoxic lymphokine (Factor 2) from a human B-cell line (Karpas 160B) by preparative isoelectric focusing in the Rotofor cell and chromatofocusingCytokine, 1993
- A Novel Monoclonal Antibody Dependent on Domain 5 of the Platelet-Derived Growth Factor Beta Receptor Inhibits Ligand Binding and Receptor ActivationGrowth Factors, 1993
- Humanized antibodies for therapyNature, 1991
- Immunohistologic Demonstration of Platelet-derived Growth Factor (PDGF) and sis-Oncogene Expression in SclerodermaJournal of Investigative Dermatology, 1989
- Platelet-derived growth factor: Identification of constituent polypeptide chainsBiochemical and Biophysical Research Communications, 1982
- A platelet factor stimulating human normal glial cellsExperimental Cell Research, 1976
- Platelets as a source of fibroblast growth-promoting activityExperimental Cell Research, 1974